At Ayala, we are dedicated to developing targeted therapies specifically for patients living with rare and aggressive diseases. In combination with next-generation sequencing and our proprietary bioinformatics platform, we are pioneering a novel approach to cancer treatment.
March 25, 2021
Ayala Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Business Update
February 19, 2021
Ayala Pharmaceuticals Announces $25 Million Strategic Financing